Chronic Fatigue Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Chronic Fatigue Syndrome, including details on myalgic encephalomyelitis (me), diagnosis, gradual and sudden onset.

Volume 2 (2006), Issue 4 (April)

1. Chronic back pain among the elderly: prevalence, associations, and predictors.
   Spine, 31(7): E203-7. [Abstract] [Full-text]
2. Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease.
   Am J Health Syst Pharm, 63(8): 731-4. [Abstract] [Full-text]
3. Electrically stimulated resistance training in SCI individuals increases muscle fatigue resistance but not femoral artery size or blood flow.
   Spinal Cord, 44(4): 227-33. [Abstract] [Full-text]
4. Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis.
   Clin Dev Immunol, 13(1): 25-39. [Abstract] [Full-text]
5. Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity.
   Clin Rheumatol, 25(3): 329-33. [Abstract] [Full-text]
6. Further development and validation of the Occupational Fatigue Exhaustion Recovery (OFER) scale.
   J Occup Environ Med, 48(4): 381-9. [Abstract] [Full-text]
7. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD.
   Chest, 129(4): 899-904. [Abstract] [Full-text]
8. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?
   Int J Epidemiol, 35(2): 468-76. [Abstract] [Full-text]
9. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology.
   Curr Opin Psychiatry, 19(1): 67-73. [Abstract] [Full-text]
10. Personal view: a potential novel treatment for fatigue complicating chronic liver disease--how should its efficacy be evaluated?
    Aliment Pharmacol Ther, 23(8): 1113-6. [Abstract] [Full-text]
11. Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.
    Pharmacogenomics, 7(3): 521-8. [Abstract] [Full-text]
12. Interpreter of maladies: redescription mining applied to biomedical data analysis.
    Pharmacogenomics, 7(3): 503-9. [Abstract] [Full-text]
13. Improved prediction of treatment response using microarrays and existing biological knowledge.
    Pharmacogenomics, 7(3): 495-501. [Abstract] [Full-text]
14. Allostatic load is associated with symptoms in chronic fatigue syndrome patients.
    Pharmacogenomics, 7(3): 485-94. [Abstract] [Full-text]
15. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome.
    Pharmacogenomics, 7(3): 475-83. [Abstract] [Full-text]
16. Chronic fatigue syndrome and high allostatic load.
    Pharmacogenomics, 7(3): 467-73. [Abstract] [Full-text]
17. Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndrome.
    Pharmacogenomics, 7(3): 455-65. [Abstract] [Full-text]
18. Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis.
    Pharmacogenomics, 7(3): 441-54. [Abstract] [Full-text]
19. Gene expression profile exploration of a large dataset on chronic fatigue syndrome.
    Pharmacogenomics, 7(3): 429-40. [Abstract] [Full-text]
20. Exploration of statistical dependence between illness parameters using the entropy correlation coefficient.
    Pharmacogenomics, 7(3): 421-8. [Abstract] [Full-text]
21. Identifying illness parameters in fatiguing syndromes using classical projection methods.
    Pharmacogenomics, 7(3): 407-19. [Abstract] [Full-text]
22. Gene expression correlates of unexplained fatigue.
    Pharmacogenomics, 7(3): 395-405. [Abstract] [Full-text]
23. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue.
    Pharmacogenomics, 7(3): 387-94. [Abstract] [Full-text]
24. The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue.
    Pharmacogenomics, 7(3): 365-73. [Abstract] [Full-text]
25. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women.
    Pharmacogenomics, 7(3): 355-64. [Abstract] [Full-text]
26. The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome.
    Pharmacogenomics, 7(3): 345-54. [Abstract] [Full-text]
27. The uremic environment and muscle dysfunction in man and rat.
    Nephron Physiol, 103(1): p33-42. [Abstract] [Full-text]
28. Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity.
    Phytother Res, 20(3): 165-8. [Abstract] [Full-text]
29. Consequences of exercise-induced respiratory muscle work.
    Respir Physiol Neurobiol, 151(2): 242-50. [Abstract] [Full-text]
30. Gene expression profile of empirically delineated classes of unexplained chronic fatigue.
    Pharmacogenomics, 7(3): 375-86. [Abstract] [Full-text]
31. Symptom control in palliative care--Part I: oncology as a paradigmatic example.
    J Palliat Med, 9(2): 391-408. [Abstract] [Full-text]
32. Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies.
    Proc Am Thorac Soc, 3(3): 270-5. [Abstract] [Full-text]
33. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
    J Gastroenterol Hepatol, 21(3): 575-80. [Abstract] [Full-text]
34. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases.
    J Neurol Sci, 244(1): 77-87. [Abstract] [Full-text]
35. Acupuncture for chronic headaches--an epidemiological study.
    Headache, 46(4): 632-41. [Abstract] [Full-text]

© 2005-2008 Chronic Fatigue Syndrome Research Today. All Rights Reserved.